Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the MEK inhibitor selumetinib Meeting Abstract

  


Authors: Ho, A. L.; Leboeuf, R.; Grewal, R. K.; Sherman, E. J.; Deandreis, D.; Pentlow, K. S.; Tuttle, R. M.; Fury, M. G.; Ricarte-Filho, J. C. M.; Pfister, D. G.; Larson, S. M.; Fagin, J. A.
Abstract Title: Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the MEK inhibitor selumetinib
Meeting Title: 48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 15 Suppl.
Meeting Dates: 2012 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-05-20
Language: English
ACCESSION: WOS:000318009801530
PROVIDER: wos
DOI: 10.1200/jco.2012.30.15_suppl.5509
Notes: Meeting Abstract: 5509^ -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. James A Fagin
    180 Fagin
  2. Robert M Tuttle
    481 Tuttle
  3. Eric J Sherman
    339 Sherman
  4. Ravinder K Grewal
    82 Grewal
  5. Rebecca Leboeuf
    13 Leboeuf
  6. David G Pfister
    389 Pfister
  7. Matthew G Fury
    102 Fury
  8. Alan Loh Ho
    237 Ho
  9. Julio Cezar Marques Ricarte Filho
    21 Ricarte Filho
  10. Steven M Larson
    958 Larson
  11. Keith S Pentlow
    70 Pentlow
Related MSK Work